Here is a list of the top ten stocks that may appear in the news on Monday:
Banks and finance: In an affidavit filed in the Supreme Court, the Reserve Bank of India warned of risks to the banking sector if the suspension on bad debt classification is not lifted immediately. It has also refused to extend its moratorium on loan repayments.
Vedanta: The company said its delisting offer is considered to have failed under the terms of the delisting regulations. In total, 125.47 crore shares were validly tendered by public shareholders. The promoters sought to buy 169.73 million shares or a 47.67% stake held by the public to eliminate the company.
Adani Companies: The company’s arm, Adani Airport Holdings, is in advanced talks with the Qatar Investment Authority to sell a minority stake in Mumbai International Airport that it acquired last month.
Naval builders of the Mazagón dock: The ₹444 million rupees of public issue of the company, which is listed today on ₹145 per share, it was underwritten more than 157 times, making it the most underwritten IPO among public sector companies. The IPO has received offers for 4.82 billion shares of capital compared to the size of the offering of 30.60 million shares.
UTI AMC: the ₹2160 crore IPO of the company listed in ₹554 per share today had received a modest response from investors. the ₹The 2,160 crore public issue witnessed a 2.31 times subscription.
State Bank of India: US-based private equity fund manager Blackstone has refinanced discounted rental loans worth ₹Rs 2,500 crore with SBI, said a report in Business Standard citing a source. It will be one of the largest LRD refinances made by a bank on commercial properties in recent years.
Wipro: The company will announce its earnings for the quarter ending today in September. The Bengaluru-based company may see its net profit in the quarter decrease from the previous year, but increase sequentially.
Indiabulls Home Financing: The lender has collected ₹Rs 440 million by selling part of its stake in UK-based OakNorth Bank Ltd to Riva Capital Partners V, LP USA for ₹441 million rupees. The proceeds of the sale will be added to the regulatory net worth and CRAR of the company,
Shilpa Medicare: The company received an email warning letter from the US FDA for its Jadcherla, Telangana facility. The company has said that it will collaborate with the agency and is fully committed to solving this issue as soon as possible.
Bharat Biotech: The company has been asked to provide complete safety and immunogenicity data and some clarification regarding the ongoing phase 2 trial of its covid-19 vaccine. It had requested the approval of the DGCI to continue with the phase 3 clinical trials of its candidate vaccine ‘Covaxin’.
.
